Historical Valuation
Cryo-Cell International Inc (CCEL) is now in the Fair zone, suggesting that its current forward PS ratio of 0.91 is considered Fairly compared with the five-year average of 20.09. The fair price of Cryo-Cell International Inc (CCEL) is between 2.57 to 7.50 according to relative valuation methord.
Relative Value
Fair Zone
2.57-7.50
Current Price：3.61
Fair
P/E
EV/EBITDA
EV/EBIT
P/S
P/OCF
P/FCF
1Y
3Y
5Y
Trailing
Forward
Cryo-Cell International Inc (CCEL) has a current Price-to-Book (P/B) ratio of -1.86. Compared to its 3-year average P/B ratio of -230.89 , the current P/B ratio is approximately -99.19% higher. Relative to its 5-year average P/B ratio of -140.44, the current P/B ratio is about -98.67% higher. Cryo-Cell International Inc (CCEL) has a Forward Free Cash Flow (FCF) yield of approximately 22.38%. Compared to its 3-year average FCF yield of 3.86%, the current FCF yield is approximately 479.25% lower. Relative to its 5-year average FCF yield of 4.59% , the current FCF yield is about 387.99% lower.
P/B
Median3y
-230.89
Median5y
-140.44
FCF Yield
Median3y
3.86
Median5y
4.59
Competitors Valuation Multiple
AI Analysis for CCEL
The average P/S ratio for CCEL competitors is 0.90, providing a benchmark for relative valuation. Cryo-Cell International Inc Corp (CCEL.A) exhibits a P/S ratio of 0.91, which is 2% above the industry average. Given its robust revenue growth of -2.99%, this premium appears unsustainable.
Performance Decomposition
AI Analysis for CCEL
1Y
3Y
5Y
Market capitalization of CCEL increased by 0.00% over the past 1 year. The primary factor behind the change was an decrease in Unknown from 0.00 to 0.00.
The secondary factor is the Unknown, contributed 0.00%to the performance.
Overall, the performance of CCEL in the past 1 year is driven by Unknown.
People Also Watch
Frequently Asked Questions
Is CCEL currently overvalued or undervalued?
Cryo-Cell International Inc (CCEL) is now in the Fair zone, suggesting that its current forward PS ratio of 0.91 is considered Fairly compared with the five-year average of 20.09. The fair price of Cryo-Cell International Inc (CCEL) is between 2.57 to 7.50 according to relative valuation methord.
What is Cryo-Cell International Inc (CCEL) fair value?
CCEL's fair value is calculated using relative valuation, based on historical P/E and P/S ranges and their premiums/discounts relative to a competitor average , adjusted by weights. The fair price of Cryo-Cell International Inc (CCEL) is between 2.57 to 7.50 according to relative valuation methord.
How does CCEL's valuation metrics compare to the industry average?
The average P/S ratio for CCEL's competitors is 0.90, providing a benchmark for relative valuation. Cryo-Cell International Inc Corp (CCEL) exhibits a P/S ratio of 0.91, which is 2.00% above the industry average. Given its robust revenue growth of -2.99%, this premium appears unsustainable.
What is the current P/B ratio for Cryo-Cell International Inc (CCEL) as of Jan 09 2026?
As of Jan 09 2026, Cryo-Cell International Inc (CCEL) has a P/B ratio of -1.86. This indicates that the market values CCEL at -1.86 times its book value.
What is the current FCF Yield for Cryo-Cell International Inc (CCEL) as of Jan 09 2026?
As of Jan 09 2026, Cryo-Cell International Inc (CCEL) has a FCF Yield of 22.38%. This means that for every dollar of Cryo-Cell International Inc’s market capitalization, the company generates 22.38 cents in free cash flow.
What is the current Forward P/E ratio for Cryo-Cell International Inc (CCEL) as of Jan 09 2026?
As of Jan 09 2026, Cryo-Cell International Inc (CCEL) has a Forward P/E ratio of -8.79. This means the market is willing to pay $-8.79 for every dollar of Cryo-Cell International Inc’s expected earnings over the next 12 months.
What is the current Forward P/S ratio for Cryo-Cell International Inc (CCEL) as of Jan 09 2026?
As of Jan 09 2026, Cryo-Cell International Inc (CCEL) has a Forward P/S ratio of 0.91. This means the market is valuing CCEL at $0.91 for every dollar of expected revenue over the next 12 months.